A REAL DIFFERENCE
IS PAVED WITH DAILY ENDEAVORS

Our mission runs through everything we do, from R&D to technical service, and from manufacturing to drug delivery.

OUR MISSION

Committed to Making High-Quality Medicines Accessible to More Patients
Founded in 2002, Chenpon Pharmaceutical has 8 subsidiaries including R&D, production, and domestic and foreign sales. The company adheres to innovation-led development, and the product categories cover digestive, psychological, respiratory, cardiovascular, cerebrovascular, anti-tumor, and surgical analgesia therapeutic areas. The company and its subsidiaries have won the honorary titles of Shanghai Science and Technology Little Giant Cultivation, Shanghai May Day Labor Medal, and Excellent Public Welfare Partner, etc.

OUR VISION

Leading Company in the Field of Pulmonary Drug Delivery Technology
From mechanical to electromechanical inhaler design, from small chemical molecule powder engineering to biological macromolecule powder technology exploration, from particle macroscopic performance characterization to microscopic performance testing, from human factors engineering to in vitro and in vivo correlation research, Chenpon has made continuous efforts to become a leading enterprise in the development of pulmonary drug delivery technology in China.
OUR CORE VALUES
Integrity, Responsibility,
Rigor, Excellence, Innovation
Core Values Guide Our Daily Practice
OUR STORIES
We Strive to Value Our Patients and Employees, and to Respect Both Society and Environment.
Voices of Our Researchers
The researchers at Chenpon believe that our daily efforts can help patients win the battle threatening their breath!
Medicine and Patients
After using the medication, the patient was able to pick up chopsticks to eat and answer calls from family. What we take for granted is a dream come true for others.
Corporate Donation
The disease is ruthless, but people are compassionate. What we deliver is not just medicine, but also our responsibility, care, and love.
A Century of Witness
Reflecting on the past, we have witnessed a century of change in the pharmaceutical industry; looking to the future, we provide everlasting momentum for innovation and creation.
OUR HORNORS
We Remain Unwavering in Our Drive to Excel in Business Performance and to Uphold Our Corporate Social Responsibility
2022
  • Shanghai Xinhuanghe Pharma won the title of 'Songjiang Intelligent Factory'
  • Shanghai Xiuxin Chenpon obtained the intellectual property management system certification
2021
  • Shanghai Xinhuanghe Pharma won the title of 'Outstanding Public Welfare Partner of the Year'
  • Shanghai Xiuxin Chenpon passed CNAS certification
2020
  • Shanghai Xinhuanghe Pharma received a certificate of donation
  • Chenpon Pharma was awarded the title of Shanghai Patent Pilot Enterprise
2019
  • Shanghai Xinhuanghe won the 'Songjiang Development and Progress Award'
2018
  • Shanghai Xinhuanghe Pharma won the May Day Labor Medal
  • Shanghai Xinhuanghe & Xiuxin Chenpon were both recognized as high-tech enterprises
2014

Chenpon was recognized as a small giant cultivation enterprise of science and technology in Shanghai

Chenpon undertook the "Science and Technology Innovation Action Plan" of Shanghai


2008
  • Chenpon Pharma was recognized as High-Tech Enterprise


OUR HISTORY
Continuing Journey of Growth and Innovation
2024
Fluticasone Propionate Nebulized Inhalation Suspension was approved for marketing
2023
25000 m² Commercial production site in G60 High-tech and Innovation Corridor (Songjiang) completed
2022
Injectable product exported to overseas market
Expansion of the production line for inhalation powder products completed
2021
R&D center obtained CNAS certificate
Vise-Chairman of Shanghai High-tech Enterprises association
2020
Hainan Chenpon obtained Class III medical device business licence certificate
Inhalation suspension preparation production line completed
2019
An injectable product approved in both the EU and China
2018
Established Chenpon overseas company, initiated product go-global strategy
Expansion of inhalation formulation research center
2017
Complete company's shareholding reform
2016
Pilot production line for dry powder formulations was completed
Production line for medical devices was completed
2014
Acquired Shanghai Xinhuanhe Pharmaceutical Co., Ltd. from Shanghai Pharmaceuticals, with its own production site
2013
Expansion of the company's analytical testing laboratory completed
2008
Established sales company Hainan Chenbang Pharmaceutical Co., Ltd.
2003
Established research and development company Shanghai Xiuxin Chenpon Pharmaceutical Technology Co., Ltd.
2002
Established Shanghai Chenpon Pharmaceutical Technology Co., Ltd.
Privacy Policy | Terms
© 2023 CHENPON Pharmaceutical. All right reserved Shanghai ICP for 17003019-1
The Internet Drug Information Service Qualification Certificate -(Shanghai)-Non-profitable-2023-015